Multisystem Inflammatory Syndrome therapies in children (MISTIC): A randomized trial()

BACKGROUND: Multisystem Inflammatory Syndrome in Children (MIS-C), which occurs 2–6 weeks after initial exposure to SARS-CoV-2, was first identified in early 2020 when patients presented with fever and significant inflammation, often requiring management in the intensive care unit. To date, there ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Jain, Sonia, He, Feng, Brown, Kiana, Burns, Jane C., Tremoulet, Adriana H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852262/
https://www.ncbi.nlm.nih.gov/pubmed/36694613
http://dx.doi.org/10.1016/j.conctc.2023.101060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852262/
https://www.ncbi.nlm.nih.gov/pubmed/36694613
http://dx.doi.org/10.1016/j.conctc.2023.101060

Ejemplares similares